DRD vs KWR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
DRD exhibits exceptional fundamental health, highlighted by a strong Piotroski F-Score of 8/9 and a pristine balance sheet with zero debt. While the stock trades at a premium to its Graham Number ($16.31), it remains significantly undervalued relative to its intrinsic value ($46.32) and analyst target price ($46.50). High profitability margins and an impressive ROE of 34.71% suggest a highly efficient operation. Despite a bearish technical trend and weak insider sentiment, the underlying financial strength and growth trajectory provide a compelling bullish case.
KWR exhibits a stark divergence between analyst optimism and fundamental health, headlined by a weak Piotroski F-Score of 2/9. While the company shows strong liquidity (Current Ratio 2.42) and impressive year-over-year earnings growth of 48.6%, current profitability is concerning with a negative profit margin (-0.13%) and negative ROE (-0.18%). The stock is currently viewed as a recovery play, supported by a 'Strong Buy' analyst consensus and a target price of $169.20, but the underlying deterministic health scores suggest significant operational instability.
Compare Another Pair
Related Comparisons
DRD vs KWR: Head-to-Head Comparison
This page compares DRDGOLD Limited (DRD) and Quaker Chemical Corporation (KWR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.